Aneurysmatische Gefäßerkrankungen: Terminologie, Ätiologie und Lokalisation

Part of the Springer Reference Medizin book series (SRM)


Bei einem Aneurysma handelt es sich um eine umschriebene Erweiterung eines Gefäßes. In diesem Kapitel werden die Ursachen der verschieden Formen und Lokalisationen von Aneurysmen dargestellt. Da die genetischen und molekularen Grundlagen vor allem am abdominellen Aortenaneurysma (AAA) untersucht worden sind, diesen diese Aneurysmen hier im Fokus. Drei Prozesse stehen hierbei im Vordergrund bei der Ausbildung solcher Aneurysmen: Die Degradation der extrazellulären Matrix, ein chronischer Entzündungsprozess sowie eine Reduktion der mesenchymalen Muskelzellen.


  1. Agarwal S (2009) The association of active and passive smoking with peripheral arterial disease: results from NHANES 1999–2004. Angiology 60:335–345 [Im Druck]PubMedCrossRefGoogle Scholar
  2. Allen EV, Brown GE (1932) Raynaud’s disease: a critical review of minimal requisites for diagnosis. Am J Med Sci 183(2):187–200CrossRefGoogle Scholar
  3. Aly S, Jenkins MP, Zaidi FH et al (1998) Duplex scanning and effect of multisegmental arterial disease on its accuracy in lower limb arteries. Eur J Vasc Endovasc Surg 16:345–349PubMedCrossRefGoogle Scholar
  4. Archer SL, Huang JM, Hampl V et al (1994) Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 91:7583–7587PubMedPubMedCentralCrossRefGoogle Scholar
  5. Avierinos JF, Gersh BJ, Melton LJ 3rd, Bailey KR, Shub C, Nishimura RA, Tajik AJ, Enriquez-Sarano M (2002) Natural history of asymptomatic mitral valve prolapse in the community. Circulation 106(11):1355–1361PubMedCrossRefGoogle Scholar
  6. Aydin MA, Koschyk DH, Karck M, Cremer J, Haverich A, Berger J, Nienaber CA, Meinertz T, von Kodolitsch Y (2002) Prädiktoren der Aneurysmaentwicklung nach chirurgischer Korrektur einer Aortenisthmusstenose. Z Kardiol 91(suppl1):I/338 (A)Google Scholar
  7. Aydin A, Mortensen K, Rybczynski M, Sheikhzadeh S, Willmann S, Bernhardt AM, Hillebrand M, Stritzke J, Baulmann J, Schunkert H, Keil U, Hense HW, Meisinger C, Robinson PN, Berger J, Willems S, Meinertz T, von Kodolitsch Y (2011) Central pulse pressure and augmentation index in asymptomatic bicuspid aortic valve disease. Int J Cardiol 147(3):466–468Google Scholar
  8. Baldwin ZK, Ceraldi CC (2003) Ergotism associated with HIV antiviral protease inhibitor therapy. J Vasc Surg 37(3):676–678PubMedCrossRefGoogle Scholar
  9. Baril DT, Carroccio A, Palchik E, Ellozy SH, Jacobs TS, Teodorescu V, Marin ML (2006) Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg 20(4):464–471PubMedCrossRefGoogle Scholar
  10. Beasley JM, Ange BA, Anderson CA, Miller ER 3rd, Erlinger TP, Holbrook JT, Sacks FM, Appel LJ (2009) Associations between macronutrient intake and self-reported appetite and fasting levels of appetite hormones: results from the optimal macronutrient intake trial to prevent heart disease. Am J Epidemiol 169:893–900PubMedPubMedCentralCrossRefGoogle Scholar
  11. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77(1):31–37Google Scholar
  12. Bekanntmachungen (2007) Beschluss des Gemeinsamen Bundesausschusses gem. § 91 Abs. 4 SGB V vom 15. August 2006. Deutsches ÄrzteblattGoogle Scholar
  13. Belch JJ, Newman P, Drury JK, McKenzie F, Capell H, Leiberman P, Forbes CD, Prentice CR (1983) Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud’s syndrome: a double-blind controlled trial. Lancet 1:313–315PubMedCrossRefGoogle Scholar
  14. Bergqvist D, Jivegard L, Holm J (1995) When is urgent revascularisation necessary for the lower limb ischemia? Eur J Vasc Endovasc Surg 9:448–453PubMedCrossRefGoogle Scholar
  15. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, Dewor M, Georgiev I, Schober A, Leng L, Kooistra T, Fingerle-Rowson G, Ghezzi P, Kleemann R, McColl SR, Bucala R, Hickey MJ, Weber C (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587–596PubMedCrossRefGoogle Scholar
  16. Bernhardt A, Treede H, Rybczynski M, Sheikzadeh S, Detter C, von Kodolitsch Y, Reichenspurner H (2011) Mitral valve surgery in patients with Marfan syndrome. J Thorac Cardiovasc Surg (under review)Google Scholar
  17. Bernhardt AM, Treede H, Rybczynski M, Sheikzadeh S, Kersten JF, Meinertz T, von Kodolitsch Y, Reichenspurner H (2011b) Comparison of aortic root replacement in patients with Marfan syndrome. Eur J Cardiothorac Surg 40:1052–1057Google Scholar
  18. Bettoni L, Geri A, Airo P, Danieli E, Cavazzana I, Antonioli C, Chiesa L, Franceschini F, Grottolo A, Zambruni A, Radaeli E, Cattaneo R (2002) Systemic sclerosis therapy with iloprost: a prospective observational study of 30 patients treated for a median of 3 years. Clin Rheumatol 21(3):244–250PubMedCrossRefGoogle Scholar
  19. Bock I (2003) Die Behandlung der arteriellen Verschlusserkrankung durch femorodistale Bypassimplantation – ein follow up nach 270 Bypassimplantationen. Inauguraldissertation, LübeckGoogle Scholar
  20. Böckler D, Lang W, Debus ES, Flessenkämper I, Florek HJ, Noppeney T, Schmitz-Rixen T, Nöldecke S, Hupp T, Eckstein H (2009) Randomisierte Studien mit EBM-Level 1 beweisen es. Gefässchirurgie 14:350–361CrossRefGoogle Scholar
  21. Bole PV, Munda R, Purdy RT, Lande A, Gomez R, Clauss RH, Kazarian KK, Mersheimer WL (1976) Traumatic pseudoaneurysms: a review of 32 cases. J Trauma 16:63–70PubMedCrossRefGoogle Scholar
  22. Bollinger A, Schlumpf M (1976) Finger blood flow in healthy subjects of different age and sex and in patients with primary Raynaud’s disease. Acta Chir Scand Suppl 465:42–47PubMedGoogle Scholar
  23. Bollinger A, Mahler F, Meier B (1977) Velocity patterns in nailfold capillaries of normal subjects and patients with Raynaud’s disease and acrocyanosis. Bibl Anat 16:142–145Google Scholar
  24. Boon RA, Horrevoets AJ (2009) Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 29:39–40PubMedCrossRefGoogle Scholar
  25. Botta L, Russo V, La Palombara C, Rosati M, Di Bartolomeo R, Fattori R (2009) Stent graft repair of descending aortic dissection in patients with Marfan syndrome: an effective alternative to open reoperation? J Thorac Cardiovasc Surg 138(5):1108–1114Google Scholar
  26. Brossmann J, Müller-Hülsbeck S, Heller M et al (1998) Perkutane Thrombektomie und mechanische Thrombolyse. Fortschr Röntgenstr 169:344–354CrossRefGoogle Scholar
  27. Caglayan E, Huntgeburth M, Karasch T, Weihrauch J, Hunzelmann N, Krieg T, Erdmann E, Rosenkranz S (2006) Phosphodiesterase type 5 inhibition is a novel therapeutic option in Raynaud’s disease. Arch Intern Med 166(2):231–233PubMedCrossRefGoogle Scholar
  28. Calligaro KD, Dougherty MJ (2005) Renal Artery Aneurysms and arteriovenous Fistulae. In: Rutherford RB (Hrsg) Vascular surgery, Bd 6. Elsevier Saunders, Philadelphia, S 1861–1870Google Scholar
  29. Cerwinka WH, Cooper D, Krieglstein CF et al (2002) Nitric oxide modulates endotoxin-induced platelet-endothelial cell adhesion in intestinal venules. Am J Physiol Heart Circ Physiol 282:1111–1117CrossRefGoogle Scholar
  30. Chelland Campbell S, Moffatt RJ, Stamford BA (2008) Smoking and smoking cessation – the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201:225–235PubMedCrossRefGoogle Scholar
  31. Chen HW, Lii CK, Ku HJ, Wang TS (2009) Cigarette smoke extract induces expression of cell adhesion molecules in HUVEC via actin filament reorganization. Environ Mol Mutagen 50:96–104PubMedCrossRefGoogle Scholar
  32. Choudhary AS, Evans RJ, Naik DK, Tripathi RK, Wickremesekera JK (2009) Surgical management of extracranial carotid artery aneurysms. ANZ J Surg 79:281–287PubMedCrossRefGoogle Scholar
  33. Cistulli PA, Gotsopoulos H, Sullivan CE (2001) Relationship between craniofacial abnormalities and sleep-disordered breathing in Marfan’s syndrome. Chest 120:1455–1460PubMedCrossRefGoogle Scholar
  34. Coffman JD, Cohen RA (1988) Role of alpha-adrenoceptor subtypes mediating sympathetic vasoconstriction in human digits. Eur J Clin Invest 18(3):309–313PubMedCrossRefGoogle Scholar
  35. Collod G, Babron MC, Jondeau G, Coulon M, Weissenbach J, Dubourg O, Bourdarias JP, Bonaiti-Pellie C, Junien C, Boileau C (1994) A second locus for Marfan syndrome maps to chromosome 3p24.2–p25. Nat Genet 198:264–268Google Scholar
  36. Costantini V, Lend M (2002) Treatment of acute occlusion of peripheral arteries. Thromb Res 106:285–294CrossRefGoogle Scholar
  37. Cotrufo M, Della Corte A (2009) The association of bicuspid aortic valve disease with asymmetric dilatation of the tubular ascending aorta: identification of a definite syndrome. J Cardiovasc Med (Hagerstown) 10(4):291–297CrossRefGoogle Scholar
  38. Curci JA, Baxter BT, Thompson RW (2005) Arterial aneurysms: etiologic considerations. In: Rutherford RB (Hrsg) Vascular surgery, Bd 6. Elsevier Saunders, Philadelphia, S 475–492Google Scholar
  39. Cyron CJ, Wilson JS, Humphrey JD (2014) Mechanobiological stability: a new paradigm to understand the enlargement of aneurysms? J R Soc Interface 11:20140680PubMedPubMedCentralCrossRefGoogle Scholar
  40. Dai G, Kaazempur-Mofrad MR, Natarajan S, Zhang Y, Vaughn S, Blackman BR, Kamm RD, García-Cardeña G, Gimbrone MA Jr (2004) Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. PNAS 101:14871–14876PubMedCrossRefGoogle Scholar
  41. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA Jr (2007) Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res 101:723–733PubMedCrossRefGoogle Scholar
  42. Davis FM, Rateri DL, Daugherty A (2014) Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 100:1498–1505PubMedCrossRefGoogle Scholar
  43. Davis FM, Rateri DL, Daugherty A (2015) Abdominal aortic aneurysm: novel mechanisms and therapies. Curr Opin Cardiol 30:566–573PubMedPubMedCentralCrossRefGoogle Scholar
  44. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62(4):417–426Google Scholar
  45. Debus ES, Kölbel T, Böckler D, Eckstein H (2010) Abdominelle Aortenaneurysmen. Gefässchirurgie 15:154–168CrossRefGoogle Scholar
  46. Dedow E, Bangemann U, Koenig H (2002) Die Ergebnisse der intraartieriellen rTPA Lyse verschlossener femoro-distaler Bypasse. In: Hepp W (Hrsg) Akuter Extremitäten-Arterienverschluß. Steinkopff, DarmstadtGoogle Scholar
  47. Deguchi J et al (2009) Genetically engineered resistance for MMP collagenases promotes abdominal aortic aneurysm formation in mice infused with angiotensin II. Lab Invest 89:315–326PubMedPubMedCentralCrossRefGoogle Scholar
  48. Der akute Gefäßverschluß – was ist zu tun?
  49. Dimmeler S, Zeiher AM (1999) Nitric oxide-an endothelial cell survival factor. Cell Death Differ 6:964–968PubMedCrossRefGoogle Scholar
  50. Dobrin PB, Baker WH, Gley WC (1984) Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. Arch Surg 119:405–409PubMedCrossRefGoogle Scholar
  51. Dormandy J, Heeck L, Vig S (1999) Acute limb ischemia. Semin Vasc Surg 12:148–153PubMedGoogle Scholar
  52. Dotter CT, Roesch J, Seaman A (1974) Selective clot lysis with low-dose streptokinase. Radiology 111:31–37PubMedCrossRefGoogle Scholar
  53. Dowd PM, Martin MF, Cooke ED, Bowcock SA, Jones R, Dieppe PA, Kirby JD (1982) Treatment of Raynaud’s phenomenon by intravenous infusion of prostacyclin (PGI2). Br J Dermatol 106(1):81–89PubMedCrossRefGoogle Scholar
  54. Duda SH, Tepe G, Luz O, Ouriel K, Dietz K, Hahn U, Pereira P, Marsalek P, Ziemer G, Erley CM, Claussen CD (2001) Peripheral artery occlusion: treatment with abciximab plus urokinase versus with urokinase alone – a randomized pilot trial (the PROMPT study). Platelet receptor antibodies in order to manage peripheral artery thrombosis. Radiology 221(3):689–96PubMedCrossRefGoogle Scholar
  55. Dziadzio M, Denton CP, Smith R, Howell K, Blann A, Bowers E, Black CM (1999) Losartan therapy for Raynaud’s phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis Rheum 42(12):2646–2655PubMedCrossRefGoogle Scholar
  56. Eadie MJ (2001) Clinically significant drug interactions with agents specific for migraine attacks. CNS Drugs 15(2):105–118PubMedCrossRefGoogle Scholar
  57. Eckstein HH (1998) Akute Extremitätenischämie. Chirurg 69:786–800PubMedCrossRefGoogle Scholar
  58. El Menyar AA (2006) Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med 52(1):51–56Google Scholar
  59. Elkind MS (2009) Inflammatory markers and stroke. Curr Cardiol Rep 11:12–20PubMedCrossRefGoogle Scholar
  60. Elmore JR, Keister BF, Franklin DP, Youkey JR, Carey DJ (1998) Expression of matrix metalloproteinases and TIMPs in human abdominal aortic aneurysms. Ann Vasc Surg 12:221–228PubMedCrossRefGoogle Scholar
  61. El-Sabrout R, Cooley DA (2000) Extracranial carotid artery aneurysms: Texas Heart Institute experience. J Vasc Surg 31:702–712PubMedCrossRefGoogle Scholar
  62. Evans JM, O’Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122:502–507PubMedCrossRefGoogle Scholar
  63. Faggioli G, Ferri M, Rapezzi C, Tonon C, Manzoli L, Stella A (2009) Atherosclerotic aortic lesions increase the risk of cerebral embolism during carotid stenting in patients with complex aortic arch anatomy. J Vasc Surg 49:80–85PubMedCrossRefGoogle Scholar
  64. Faivre L, Collod-Beroud G, Loeys BL, Child A, Binquet C, Gautier E, Callewaert B, Arbustini E, Mayer K, Arslan-Kirchner M, Kiotsekoglou A, Comeglio P, Marziliano N, Dietz HC, Halliday D, Beroud C, Bonithon-Kopp C, Claustres M, Muti C, Plauchu H, Robinson PN, Ades LC, Biggin A, Benetts B, Brett M, Holman KJ, De Backer J, Coucke P, Francke U, De Paepe A, Jondeau G, Boileau C (2007) Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 281(3):454–466Google Scholar
  65. Fillinger MF, Raghavan ML, Marra SP, Cronenwett JL, Kennedy FE (2002) In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg 36:589–597PubMedCrossRefGoogle Scholar
  66. Foresta C, Caretta N, Corona G, Fabbri A, Francavilla S, Jannini E, Maggi M, Bettocchi C, Lenzi A (2009) Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart. Int J Androl 32(3):198–211PubMedCrossRefGoogle Scholar
  67. Friedman EA, Harris PA, Wood AJ, Stein CM, Kurnik D (2007) The effects of tadalafil on cold-induced vasoconstriction in patients with Raynaud’s phenomenon. Clin Pharmacol Ther 81(4):503–509PubMedPubMedCentralCrossRefGoogle Scholar
  68. Fries R, Shariat K, von Wilmowsky H, Bohm M (2005) Sildenafil in the treatment of Raynaud’s phenomenon resistant to vasodilatory therapy. Circulation 112:2980–2985Google Scholar
  69. Fusco MR, Harrigan MR (2010) Cerebrovascular dissections: a review part II. Blunt cerebrovascular injury. Neurosurgery 68(2):517–553CrossRefGoogle Scholar
  70. Gambaryan S, Kobsar A, Hartmann S et al (2008) NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 6:1376–1384PubMedCrossRefGoogle Scholar
  71. Gardinali M, Pozzi MR, Bernareggi M, Montani N, Allevi E, Catena L, Cugno M, Bottasso B, Stabilini R (2001) Treatment of Raynaud’s phenomenon with intravenous prostaglandin E1 alpha-cyclodextrin improves endothelial cell injury in systemic sclerosis. J Rheumatol 28(4):786–794PubMedGoogle Scholar
  72. Geerts CC, Bots ML, Grobbee DE, Uiterwaal CS (2008) Parental smoking and vascular damage in young adult offspring: is early life exposure critical? The atherosclerosis risk in young adults study. Arterioscler Thromb Vasc Biol 28:2296–2302PubMedCrossRefGoogle Scholar
  73. Geisbusch P, Kotelis D, von Tengg-Kobligk H, Hyhlik-Durr A, Allenberg JR, Bockler D (2008) Thoracic aortic endografting in patients with connective tissue diseases. J Endovasc Ther 15(2):144–149Google Scholar
  74. Giannoglou G, Giannakoulas G, Hatzitolios AI, Rudolf J (2008) Rupture risk of abdominal aortic aneurysms. The role of computational mechanics. Herz 33:354–361PubMedCrossRefGoogle Scholar
  75. Gott VL, Greene PS, Alejo DE, Cameron DE, Naftel DC, Miller DC et al (1999) Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med 340(17):1307–13PubMedCrossRefGoogle Scholar
  76. Gray JR, Davies SJ (1996) A clinical severity grading scale for Marfan syndrome. J Med Genet 33(9):758–759PubMedPubMedCentralCrossRefGoogle Scholar
  77. Gross J, Lapiere CM (1962) Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci U S A 48:1014–1022PubMedPubMedCentralCrossRefGoogle Scholar
  78. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC (2006) Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117–121PubMedPubMedCentralCrossRefGoogle Scholar
  79. Halter G, Orend KH, Sunder-Plassmann L (2003) Die akute Extremitätenischämie. Chirurg 74:1118–1127PubMedCrossRefGoogle Scholar
  80. Hellenthal FA, Geenen IL, Teijink JA, Heeneman S, Schurink GW (2008) Histological features of human abdominal aortic aneurysm are not related to clinical characteristics. Cardiovasc Pathol 18(5):286–293PubMedCrossRefGoogle Scholar
  81. Henke PK (2009) Contemporary management of acute limb ischemia: factors associated with amputation and in-hospital mortality. Semin Vasc Surg 22:34–40PubMedCrossRefGoogle Scholar
  82. Hepp W (2002) Akuter Extremitäten-Arterienverschluß. Steinkopff, DarmstadtCrossRefGoogle Scholar
  83. Herskowitz MM, Gillego V, Ward M, Wright G (2002) Cocaine-induced mesenteric ischemia: treatment with intra-arterial papaverine. Emerg Radiol 9(3):172–174PubMedCrossRefGoogle Scholar
  84. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, Eagle KA, Hermann LK, Isselbacher EM, Kazerooni EA, Kouchoukos NT, Lytle BW, Milewicz DM, Reich DL, Sen S, Shinn JA, Svensson LG, Williams DM (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease: a report of the American college of cardiology foundation/American heart association task force on practice guidelines, American association for thoracic surgery, American college of radiology, American stroke association, society of cardiovascular anesthesiologists, society for cardiovascular angiography and interventions, society of interventional radiology, society of thoracic surgeons, and society for vascular medicine. Circulation 121(13):e266–e369PubMedGoogle Scholar
  85. Hirsch AT, Haskal ZJ, Hertzer NR (2006) ACC/AHA guidelines for the management of patients with peripheral arterial disease. J Vasc Interv Radiol 17:1383–1387PubMedCrossRefGoogle Scholar
  86. Hirschl M, Katzenschlager R, Francesconi C, Kundi M (2004) Low level laser therapy in primary Raynaud’s phenomenon – results of a placebo controlled, double blind intervention study. J Rheumatol 31(12):2408–2412PubMedGoogle Scholar
  87. Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, Kral CA, Tazelaar HD (2006) Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30(9):1159–1168PubMedCrossRefGoogle Scholar
  88. Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, Kral CA, Tazelaar HD (2008) Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 30(9):1159–1168Google Scholar
  89. Husmann MJ, Barton M, Jacomella V, Silvestro V, Amann-Vesti B (2006) Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral atherosclerosis. J Vasc Surg 44(5):993–997PubMedCrossRefGoogle Scholar
  90. Jahnke TH (2010) Management akuter Extremitätenischämien. In: Lindhoff-Last E, Debus ES, Kellersmann R, Tepe G (Hrsg) Handbuch Interdisziplinäre Angiologie, Kap. 12. Springer, Berlin/Heidelberg/New YorkGoogle Scholar
  91. Jamieson GG, Ludbrook J, Wilson A (1971) Cold hypersensitivity in Raynaud’s phenomenon. Circulation 44:254–264PubMedCrossRefGoogle Scholar
  92. Jivegard L, Holm J, Schersten T (1998) Acute limb ischemia due to arterial embolism or thrombosis: influence of limb ischemia versus pre-existing cardiac disease on postoperative mortality rate. J Cardiovasc Surg 29:32–36Google Scholar
  93. Jülke M, Leu HJ (1985) Extraaortale arterielle Aneurysmen. Analyse von 163 Aneurysmen bei 142 Patienten. Schweiz Med Wochenschr 115:10–13PubMedGoogle Scholar
  94. Juvonen J, Juvonen T, Laurila A, Alakarppa H, Lounatmaa K, Surcel HM, Leinonen M, Kairaluoma MI, Saikku P (1996) Immunohistochemical detection of Chlamydia pneumoniae in abdominal aortic aneurysms. Ann N Y Acad Sci 800:236–238PubMedCrossRefGoogle Scholar
  95. Kalinowski M, Wagner H-J (2003) Adjunctive techniques in percutaneous mechanical thrombectomy. Tech Vasc Interv Radio 6:6–13CrossRefGoogle Scholar
  96. Kallio K et al (2009) Decreased aortic elasticity in healthy 11-year-old children exposed to tobacco smoke. Pediatrics 123(2):e267–e273PubMedCrossRefGoogle Scholar
  97. Kasashima S, Zen Y, Kawashima A, Konishi K, Sasaki H, Endo M, Matsumoto Y, Kawakami K, Kasashima F, Moriya M, Kimura K, Ohtake H, Nakanuma Y (2008) Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am J Surg Pathol 32:197–204PubMedCrossRefGoogle Scholar
  98. Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F (2009) A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg 49:1264–1271 [im Druck]PubMedCrossRefGoogle Scholar
  99. Keller G, Zimmer G, Mall G, Ritz E, Amann K (2003) Nephron number in patients with primary hypertension. N Engl J Med 348:101–108PubMedCrossRefGoogle Scholar
  100. Khanafer KM, Bull JL, Upchurch GR Jr, Berguer R (2007) Turbulence significantly increases pressure and fluid shear stress in an aortic aneurysm model under resting and exercise flow conditions. Ann Vasc Surg 21:67–74PubMedCrossRefGoogle Scholar
  101. Kimmelstiel P, Wilson C (1936) Benign and malignant hypertension and nephrosclerosis. A clinical and pathological study. Am J Pathol 12:45–48PubMedPubMedCentralGoogle Scholar
  102. Knoflach M et al (2009) Cardiovascular risk factors and atherosclerosis in young women. Atherosclerosis risk factors in female youngsters (ARFY study). Stroke 40:1063–1069 [im Druck]PubMedCrossRefGoogle Scholar
  103. Knosalla C, Weng YG, Hammerschmidt R, Pasic M, Schmitt-Knosalla I, Grauhan O, Dandel M, Lehmkuhl HB, Hetzer R (2007) Orthotopic heart transplantation in patients with Marfan syndrome. Ann Thorac Surg 83(5):1691–1695PubMedCrossRefGoogle Scholar
  104. Koch AE, Haines GK, Rizzo RJ, Radosevich JA, Pope RM, Robinson PG, Pearce WH (1990) Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 137:1199–1213PubMedPubMedCentralGoogle Scholar
  105. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C (2009) Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med 15:97–103Google Scholar
  106. Kretschmer G, Teufelsbauer H (2009) Akuter peripherer Arterienverschluß (ALI).
  107. Kroger K (2006) Systemische und regionale Fibrinolyse peripherer arterieller Verschlüsse. Hamostaseologie 26:214PubMedCrossRefGoogle Scholar
  108. Kubes P, Suzuki M, Granger DN (1991) Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88:4651–4655PubMedPubMedCentralCrossRefGoogle Scholar
  109. Kuhnert SM, Phillips WJ, Davis MD (1999) Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol 135(12):1447–1449PubMedCrossRefGoogle Scholar
  110. Kunz R (1980) Aneurysmata bei 35380 Autopsien [Aneurysms in 35,380 autopsies]. Schweiz Med Wochenschr 110:142–148PubMedGoogle Scholar
  111. Kyle MV, Belcher G, Hazleman BL (1992) Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud’s phenomenon. J Rheumatol 19(9):1403–1406PubMedGoogle Scholar
  112. Larena-Avellaneda A, Debus ES, Daum H, Kindel M, Gross-Fengels W, Imig H (2004) Mycotic aneurysms affecting both lower legs of a patient with Candida endocarditis – endovascular therapy and open vascular surgery. Ann Vasc Surg 18:130–133PubMedCrossRefGoogle Scholar
  113. Lederle FA, Nelson DB, Joseph AM (2003) Smokers’ relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg 38:329–334PubMedCrossRefGoogle Scholar
  114. LeRoy EC, Medsger TA (1992) Raynaud’s phenomenon: a proposal for classification. Clin Exp Rheumatol 10(5):485–488PubMedGoogle Scholar
  115. Levi N, Schroeder TV (1997) Arteriosclerotic femoral artery aneurysms. A short review. J Cardiovasc Surg 38:335–338Google Scholar
  116. Levien TL (2006) Phosphodiesterase inhibitors in Raynaud’s phenomenon. Ann Pharmacother 40(7–8):1388–1393PubMedCrossRefGoogle Scholar
  117. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, García-Cardeña G, Jain MK (2005) Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res 96:e48–e57PubMedCrossRefGoogle Scholar
  118. Ljungberg LU, Persson K (2008) Effect of nicotine and nicotine metabolites on angiotensin-converting enzyme in human endothelial cells. Endothelium 15:239–245PubMedCrossRefGoogle Scholar
  119. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC (2005) A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 37:275–281Google Scholar
  120. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, Hilhorst-Hofstee Y, Jondeau G, Faivre L, Milewicz DM, Pyeritz RE, Sponseller PD, Wordsworth P, De Paepe AM (2010) The revised Ghent nosology for the Marfan syndrome. J Med Genet 47(7):476–485Google Scholar
  121. Lopez-Candales A, Holmes DR, Liao S, Scott MJ, Wickline SA, Thompson RW (1997) Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. Am J Pathol 150:993–1007PubMedPubMedCentralGoogle Scholar
  122. Maegdefessel L, Dalman RL, Tsao PS (2014) Pathogenesis of abdominal aortic aneurysms: microRNAs, proteases, genetic associations. Annu Rev Med 65:49–62PubMedCrossRefGoogle Scholar
  123. Maga P, Kuzdzal J, Nizankowski R, Szczeklik A, Sladek K (2007) Long-term effects of thoracic sympathectomy on microcirculation in the hands of patients with primary Raynaud disease. J Thorac Cardiovasc Surg 133(6):1428–1433PubMedCrossRefGoogle Scholar
  124. Mahler F, Meier B, Frey R, Bollinger A, Anliker M (1977) Reaction of red blood cell velocity in nailfold capillaries to local cold in patients with vasospastic disease. Bibl Anat 16:155–158Google Scholar
  125. Mahler F, Saner H, Boss CH, Annaheim M (1987) Local cold exposure for capillaroscopic examination of patients with Raynaud’s syndrome. Microvasc Res 33:422–427PubMedCrossRefGoogle Scholar
  126. Manow ML, Paulsen N, Rybczynski M, Mir T, Bernhardt AM, Treede H, Ohm G, Fuisting B, Rehder U, Meier F, Vogler M, Meinertz T, Overlack K, von Kodolitsch Y (2010) Analysis of costs and profits of ambulatory care of Marfan patients after initiation of a novel German legal directive (section sign 116 b SGB V). Med Klin (Munich) 105(8):529–537Google Scholar
  127. Marcucci M et al (2007) The role of cross-over bypass graft in the treatmment of acute ischemia of the lower limb. G Chir 28:277–280PubMedGoogle Scholar
  128. Marfan Hilfe (Deutschland) e.V. (2007) Marfan-Syndrom: Ein Ratgeber für Patienten, Angehörige und Betreuende. Steinkopff, DarmstadtCrossRefGoogle Scholar
  129. Maricq HR, Spencer-Green G, LeRoy EC (1975) Abnormal capillary patterns and systemic disease in scleroderma (progressive systemic sclerosis). Bibl Anat 13:248–249PubMedGoogle Scholar
  130. Maricq HR, LeRoy EC, D’Angelo WA, Medsger TA, Rodnan GP, Sharp GC, Wolfe JF (1980) Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23(2):183–189PubMedCrossRefGoogle Scholar
  131. Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR (2006) Predictive value of nailfold capillaroscopy in patients with Raynaud’s phenomenon. Clin Rheumatol 25(2):153–158PubMedCrossRefGoogle Scholar
  132. Milewicz DM, Guo DC, Tran-Fadulu V, Lafont AL, Papke CL, Inamoto S, Kwartler CS, Pannu H (2008) Genetic basis of thoracic aortic aneurysms and dissections: focus on smooth muscle cell contractile dysfunction. Annu Rev Genomics Hum Genet 9:283–302PubMedCrossRefGoogle Scholar
  133. Miller DC (2003) Valve-sparing aortic root replacement in patients with the Marfan syndrome. J Thorac Cardiovasc Surg 125(4):773–778PubMedCrossRefGoogle Scholar
  134. Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry M-C, Tazelaar HD (2006) Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30:1150–1158PubMedCrossRefGoogle Scholar
  135. Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N (2004) Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 36:855–860PubMedPubMedCentralCrossRefGoogle Scholar
  136. Moore WS (2006) Vascular and endovascular surgery: a comprehensive review, 7. Aufl. Saunders Elsevier, PhiladelphiaGoogle Scholar
  137. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, Saikku P, Juvonen T (2001) Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg 34:606–610PubMedCrossRefGoogle Scholar
  138. Naqi SA, Khan HM, Akhtar S, Shah TA (2006) Femoral pseudoaneurysm in drug addicts – excision without revascularization is a viable option. Eur J Vasc Endovasc Surg 31:585–587PubMedCrossRefGoogle Scholar
  139. Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD (1994) Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 14:1315–1320PubMedCrossRefGoogle Scholar
  140. Ni M, Wang Y, Zhang M, Zhang PF, Ding SF, Liu CX, Liu XL, Zhao YX, Zhang Y (2009) Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am J Physiol Heart Circ Physiol 296(5):H1598–H1606PubMedCrossRefGoogle Scholar
  141. Nishio E, Fukushima K, Shiozaki M et al (1996) Nitric oxide donor SNAP induces apoptosis in smooth muscle cells through cGMP-independent mechanism. Biochem Biophys Res Commun 221:163–168PubMedCrossRefGoogle Scholar
  142. Nordon IM, Hinchliffe RJ, Holt PJ, Morgan R, Jahangiri M, Loftus IM, Thompson MM (2009) Endovascular management of chronic aortic dissection in patients with Marfan syndrome. J Vasc Surg 50(5):987–991PubMedCrossRefGoogle Scholar
  143. Norgren L, Watt W, Dormandy J, Nehler M, Harris K, Fowkes F (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg 33(Suppl 1):1–75CrossRefGoogle Scholar
  144. Norwood MG, Lloyd GM, Moore S, Patel N, Panditi S, Sayers RD (2004) The changing face of femoral artery false aneurysms. Eur J Vasc Endovasc Surg 27:385–388PubMedCrossRefGoogle Scholar
  145. Ohman MK, Shen Y, Obimba CI, Wright AP, Warnock M, Lawrence DA, Eitzman DT (2008) Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 117:798–805PubMedPubMedCentralCrossRefGoogle Scholar
  146. Otto F (1996) Femorocrurale Gefäßrekonstruktion bei fortgeschrittener peripherer arterieller Verschlußerkrankung. Inauguraldissertation, LübeckGoogle Scholar
  147. Ouriel K, Shorten CK, DeWeese JA, Green RM, Francis CW, Azodo MV, Gutierrez OH, Manzione JV, Cox C, Marder VJ (1994) A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19(6):1021–1030PubMedCrossRefGoogle Scholar
  148. Ouriel K, Veith FJ, Sasahara AA (1998) A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or peripheral arterial surgery (TOPAS) investigators. N Engl J Med 338(16):1105–1111PubMedCrossRefGoogle Scholar
  149. Pacifico L et al (2008) Nonalcoholic fatty liver disease and carotid atherosclerosis in children. Pediatr Res 63:423–427PubMedCrossRefGoogle Scholar
  150. Park YM, Febbraio M, Silverstein RL (2009) CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J Clin Invest 119:136–145PubMedGoogle Scholar
  151. Parmar KM, Nambudiri V, Dai G, Larman HB, Gimbrone MA Jr, García-Cardeña G (2005) Statins exert endothelial atheroprotective effects via the KLF2 transcription factor. J Biol Chem 280:26714–26719PubMedCrossRefGoogle Scholar
  152. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr, García-Cardeña G (2006) Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 116:49–58PubMedCrossRefGoogle Scholar
  153. Plate G, Jansson I, Forssell C, Weber P, Oredsson S (2006) Thrombolysis for acute lower limb Ischaemla – a prospective, randomised, multicentre study comparing two strategies. Eur J Vasc Endovasc Surg 31:651–660PubMedCrossRefGoogle Scholar
  154. Ponnuswamy P, Ostermeier E, Schroettle A, Chen J, Huang PL, Ertl G, Nieswandt B, Kuhlencordt PJ (2009) Oxidative stress and compartment of gene expression determine proatherosclerotic effects of inducible nitric oxide synthase. Am J Pathol 174:2400–2410PubMedPubMedCentralCrossRefGoogle Scholar
  155. Powell JT, Bashir A, Dawson S, Vine N, Henney AM, Humphries SE, Greenhalgh RM (1990) Genetic variation on chromosome 16 is associated with abdominal aortic aneurysm. Clin Sci (Lond) 78:13–16CrossRefGoogle Scholar
  156. Pyeritz RE, McKusick VA (1979) The Marfan syndrome: diagnosis and management. N Engl J Med 300:772–777PubMedCrossRefGoogle Scholar
  157. Rademaker M, Cooke ED, Almond NE, Beacham JA, Smith RE, Mant TG, Kirby JD (1989) Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud’s phenomenon in patients with systemic sclerosis: a double blind randomized study. BMJ 298:561–564PubMedPubMedCentralCrossRefGoogle Scholar
  158. Radomski MW, Palmer RM, Moncada S (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin. Br J Pharmacol 92(3):639–646PubMedPubMedCentralCrossRefGoogle Scholar
  159. Raghunath M, Nienaber CA, von Kodolitsch Y (1997) 100 Jahre Marfan-Syndrom – eine Bestandsaufnahme. Dtsch Ärztebl 94:A–821–A30Google Scholar
  160. Raparia K, Molina CP, Quiroga-Garza G et al (2013) Inflammatory aortic aneurysm: possible manifestation of IgG4-related sclerosing disease. Int J Clin Exp Pathol 6:469–475PubMedPubMedCentralGoogle Scholar
  161. Rapp JH, Pan XM, Neumann M, Hong M, Hollenbeck K, Liu J (2008) Microemboli composed of cholesterol crystals disrupt the blood-brain barrier and reduce cognition. Stroke 39:2354–2361PubMedCrossRefGoogle Scholar
  162. Rasmussen TE, Hallett JW Jr, Metzger RL, Richardson DM, Harmsen WS, Goronzy JJ, Weyand CM (1997) Genetic risk factors in inflammatory abdominal aortic aneurysms: polymorphic residue 70 in the HLA-DR B1 gene as a key genetic element. J Vasc Surg 25:356–364PubMedCrossRefGoogle Scholar
  163. Riccardi MT, Chialà A, Lannone F, Grattagliano V, Covelli M, Lapadula G (2007) Treatment of digital ulcers in systemic sclerosis with endothelin-1 receptor antagonist (bosentan). Reumatismo 59(2):135–139PubMedGoogle Scholar
  164. Rusch NJ, Shepherd JT, Vanhoutte PM (1981) The effect of profound cooling on adrenergic neurotransmission in canine cutaneous veins. J Physiol 311:57–65PubMedPubMedCentralCrossRefGoogle Scholar
  165. Rustin MH, Almond NE, Beacham JA, Brooks RJ, Jones DP, Cooke ED, Dowd PM (1987) The effect of captopril on cutaneous blood flow in patients with primary Raynaud’s phenomenon. Br J Dermatol 117(6):751–758PubMedCrossRefGoogle Scholar
  166. Rutherford RB (2009) Clinical staging of acute limb ischemia as the basis for choice of revascularization method: when and how to intervene. Semin Vasc Surg 22:5–9PubMedCrossRefGoogle Scholar
  167. Rutherford RB, Baker JD, Ernst C et al (1997) Recommended standards for reports dealing with lower extremity Ischemia: revised version. J Vasc Surg 26:517–528PubMedCrossRefGoogle Scholar
  168. Rybczynski M, Koschyk D, Aydin MA, Robinson PN, Brinken T, Franzen O, Berger J, Hofmann T, Meinertz T, von Kodolitsch Y (2007) Tissue Doppler imaging identifies myocardial dysfunction in adults with Marfan syndrome. Clin Cardiol 30:19–24Google Scholar
  169. Rybczynski M, Koschyk D, Karmeier A, Gessler N, Sheikhzadeh S, Bernhardt AM, Habermann CR, Treede H, Berger J, Robinson PN, Meinertz T, von Kodolitsch Y (2010a) Frequency of sleep apnea in adults with the Marfan syndrome. Am J Cardiol 105(12):1836–1841Google Scholar
  170. Rybczynski M, Mir TS, Sheikhzadeh S, Bernhardt AM, Schad C, Treede H, Veldhoen S, Groene EF, Kuhne K, Koschyk D, Robinson PN, Berger J, Reichenspurner H, Meinertz T, von Kodolitsch Y (2010b) Frequency and age-related course of Mitral valve dysfunction in the Marfan syndrome. Am J Cardiol 106(7):1048–1053Google Scholar
  171. S3-Leltlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit (PAVK). AWMF-Register Nr. 065/003 Entwicklungsstufe 3 Deutsche Gesellschaft für Angiologie Gesellschaft für Gefäßmedizin. Bearbeitungsstand 27.4.2009Google Scholar
  172. Sakata N, Tashiro T, Uesugi N, Kawara T, Furuya K, Hirata Y, Iwasaki H, Kojima M (2008) IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am J Surg Pathol 32:553–559PubMedCrossRefGoogle Scholar
  173. Sato Y, Hatakeyama K, Marutsuka K, Asada Y (2008) Incidence of asymptomatic coronary thrombosis and plaque disruption: comparison of non-cardiac and cardiac deaths among autopsy cases. Thromb Res 124(1):19–23PubMedCrossRefGoogle Scholar
  174. Schwarzberg H (1998) Lokale Fibrinolyse peripher arterieller Gefäßverschlüsse. Fortschr Röntgenstr 169:227–235CrossRefGoogle Scholar
  175. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone MA Jr, García-Cardeña G, Jain MK (2004) KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation. J Exp Med 199:1305–1315PubMedPubMedCentralCrossRefGoogle Scholar
  176. Shah PK (2009) Inflammation and plaque vulnerability. Cardiovasc Drugs Ther 23:31–40PubMedCrossRefGoogle Scholar
  177. Sheen VL, Jansen A, Chen MH, Parrini E, Morgan T, Ravenscroft R, Ganesh V, Underwood T, Wiley J, Leventer R, Vaid RR, Ruiz DE, Hutchins GM, Menasha J, Willner J, Geng Y, Gripp KW, Nicholson L, Berry-Kravis E, Bodell A, Apse K, Hill RS, Dubeau F, Andermann F, Barkovich J, Andermann E, Shugart YY, Thomas P, Viri M, Veggiotti P, Robertson S, Guerrini R, Walsh CA (2005) Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology 64(2):254–262PubMedCrossRefGoogle Scholar
  178. Shekarriz H, Wenk H, Kaiser M, Köppe K, Müller G, Moubayed P (1996) Korrekturbedürftige Veränderungen der Kniekehlenarterie. Indikation, Verfahrenswahl und Ergebnisse. Gefässchirurgie 1:225–230Google Scholar
  179. Shibamura H, Olson JM, van Vlijmen-Van Keulen C, Buxbaum SG, Dudek DM, Tromp G, Ogata T, Skunca M, Sakalihasan N, Pals G, Limet R, MacKean GL, Defawe O, Verloes A, Arthur C, Lossing AG, Burnett M, Sueda T, Kuivaniemi H (2004) Genome scan for familial abdominal aortic aneurysm using sex and family history as covariates suggests genetic heterogeneity and identifies linkage to chromosome 19q13. Circulation 109:2103–2108Google Scholar
  180. Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and benefit of long-term ß-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330:1335–1341PubMedCrossRefGoogle Scholar
  181. Shteinberg D, Halak M, Shapiro S, Kinarty A, Sobol E, Lahat N, Karmeli R (2000) Abdominal aortic aneurysm and aortic occlusive disease: a comparison of risk factors and inflammatory response. Eur J Vasc Endovasc Surg 20:462–465PubMedCrossRefGoogle Scholar
  182. Silverman DI, Burton KJ, Gray J, Bosner MS, Kouchoukos NT, Roman MJ, Boxer M, Devereux RB, Tsipouras P (1995) Life expectancy in the Marfan syndrome. Am J Cardiol 175:157–160CrossRefGoogle Scholar
  183. Smith CD, McKendry RVR (1982) Controlled trial of nifedipine in the treatment of Raynaud’s phenomon. Lancet 2:1299–1301PubMedCrossRefGoogle Scholar
  184. Sommer G et al (2009) Secretory products form human adiocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem 106:729–737PubMedCrossRefGoogle Scholar
  185. Spalding KL et al (2008) Dynamics of fat cell turnover in humans. Nature 453:783–787PubMedCrossRefGoogle Scholar
  186. Stanley JC (2002) Mesenteric arterial occlusive and aneurysmal disease. Cardiol Clin 20(611–22):viiGoogle Scholar
  187. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML, American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, Council on Nutrition, Physical Activity, and Metabolism (2009) Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American heart association atherosclerosis, hypertension, and obesity in the young committee of the council on cardiovascular disease in the young; council on cardiovascular nursing; and council on nutrition, physical activity, and metabolism. Circulation 119:628–647PubMedCrossRefGoogle Scholar
  188. STILE (1994) Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220(3):251–266CrossRefGoogle Scholar
  189. Stone JR (2011) Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 23:88–94PubMedCrossRefGoogle Scholar
  190. Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA, Eggebrecht H, Elefteriades JA, Erbel R, Gleason TG, Lytle BW, Mitchell RS, Nienaber CA, Roselli EE, Safi HJ, Shemin RJ, Sicard GA, Sundt TM 3rd, Szeto WY, Wheatley GH 3rd (2008) Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stent-grafts. Ann Thorac Surg 85(1 Suppl):S1–S41PubMedCrossRefGoogle Scholar
  191. Szabo Z, Crepeau MW, Mitchell AL, Stephan MJ, Puntel RA, Yin Loke K, Kirk RC, Urban Z (2006) Aortic aneurysmal disease and cutis laxa caused by defects in the elastin gene. J Med Genet 43(3):255–258PubMedCrossRefGoogle Scholar
  192. Tabas I (2009) Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal 11(9):2333–2339PubMedPubMedCentralCrossRefGoogle Scholar
  193. Takagi H, Manabe H, Kawai N, Goto SN, Umemoto T (2009) Circulating matrix metalloproteinase-9 concentrations and abdominal aortic aneurysm presence: a meta-analysis. Interact Cardiovasc Thorac Surg 9:437–440PubMedCrossRefGoogle Scholar
  194. Tepe G, Hopfenzitz C, Dietz K, Wiskirchen J, Heller S, Ouriel K, Ziemer G, Claussen CD, Duda SH (2006) Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis-APART trial. Radiology 239(3):892–900PubMedCrossRefGoogle Scholar
  195. Thompson RW, Curci JA, Ennis TL et al (2006) Pathophysiology of abdominal aortic aneurysms: insights from the elastase-induced model in mice with different genetic backgrounds. Ann N Y Acad Sci 1085:59–73PubMedCrossRefGoogle Scholar
  196. Tiek J, Fourneau I, Daenens K, Nevelsteen A (2009) The role of thrombolysis in acute infrainguinal bypass occlusion: a prospektive nonrandomized controlled study. Ann Vasc Surg 23(2):179–185PubMedCrossRefGoogle Scholar
  197. Tosi S, Marchesoni A, Messina K, Bellintani C, Sironi G, Faravelli C (1987) Treatment of Raynaud’s phenomenon with captopril. Drugs Exp Clin Res 13(1):37–42PubMedGoogle Scholar
  198. Tousoulis D, Briasoulis A, Papageorgiou N, Antoniades C, Stefanadis C (2008) Candidate gene polymorphisms and the 9p21 locus in acute coronary syndromes. Trends Mol Med 14:441–449PubMedCrossRefGoogle Scholar
  199. Urbonavicius S, Urbonaviciene G, Honore B, Henneberg EW, Vorum H, Lindholt JS (2008) Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture – a systematic review. Eur J Vasc Endovasc Surg 36:273–280, discussion 281–2PubMedCrossRefGoogle Scholar
  200. Vaglio A, Buzio C (2005) Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 17:34–40PubMedCrossRefGoogle Scholar
  201. Vaglio A, Greco P, Corradi D, Palmisano A, Martorana D, Ronda N, Buzio C (2006) Autoimmune aspects of chronic periaortitis. Autoimmun Rev 5:458–464PubMedCrossRefGoogle Scholar
  202. van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, Vriend G, Pattynama PM, Collee M, Majoor-Krakauer D, Poldermans D, Frohn-Mulder IM, Micha D, Timmermans J, Hilhorst-Hofstee Y, Bierma-Zeinstra SM, Willems PJ, Kros JM, Oei EH, Oostra BA, Wessels MW, Bertoli-Avella AM (2011) Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 43:121–126Google Scholar
  203. Verloes A, Sakalihasan N, Koulischer L, Limet R (1995) Aneurysms of the abdominal aorta: familial and genetic aspects in three hundred thirteen pedigrees. J Vasc Surg 21:646–655PubMedCrossRefGoogle Scholar
  204. Vine N, Powell JT (1991) Metalloproteinases in degenerative aortic disease. Clin Sci (Lond) 81:233–239CrossRefGoogle Scholar
  205. von Kodolitsch Y, Rybczinsky M (2004) Cardiovascular aspects of the Marfan syndrome – a systematic review. In: Robinson PN, Godfrey M (Hrsg) Marfan syndrome: a primer for clinicians and scientists. and Kluwer Academic/Plenum Publishers, New York, S 45–69Google Scholar
  206. von Kodolitsch Y, Rybczynski M (2006) Marfan-Syndrom: Sport und Fitness. In: Marfan-Syndrom. Ein Ratgeber für Patienten, Angehörige und Betreuende. Marfan Hilfe (Deutschland) e.V. Steinkopff, DarmstadtGoogle Scholar
  207. von Kodolitsch Y, Raghunath M, Karck M, Haverich A, Nienaber CA (1998) The Marfan syndrome: therapeutic approach to cardiovascular manifestations. Z Kardiol 87:173–184Google Scholar
  208. von Kodolitsch Y, Rybczynski M, Trivic V, Hofmann T, Meinertz T (2002) In Kompetenzzentren behandeln: Lebensqualität und Lebenserwartung beim Marfan-Syndrom verbessern. Klinikarzt 31:201–206Google Scholar
  209. von Kodolitsch Y, Arslan-Kirchner M, Vogler M, Rybczynski M (2008a) Das Marfan-Syndrom – eine Übersicht. Internist Prax 48:233Google Scholar
  210. von Kodolitsch Y, Rybczynski M, Detter C, Robinson PN (2008b) Diagnosis and management of Marfan syndrome. Future Cardiol 4(1):85–96Google Scholar
  211. von Kodolitsch Y, Rybczynski M, Bernhardt A, Mir TS, Treede H, Dodge-Khatami A, Robinson PN, Sheikhzadeh S, Reichenspurner H, Meinertz T (2010) Marfan syndrome and the evolving spectrum of heritable thoracic aortic disease: do we need genetics for clinical decisions? Vasa 39(1):17–32Google Scholar
  212. Wang Y, Ait-Oufella H, Herbin O et al (2010) TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 120:422–432PubMedPubMedCentralCrossRefGoogle Scholar
  213. Wang Q, Liu Z, Ren J et al (2015) Receptor-interacting protein kinase 3 contributes to abdominal aortic aneurysms via smooth muscle cell necrosis and inflammation. Circ Res 116:600–611PubMedPubMedCentralCrossRefGoogle Scholar
  214. Wenk H (1998) Akuter Arterienverschluß bei arteriosklerotisch vorgeschädigtem Gefäß. Chirurg 69:585PubMedCrossRefGoogle Scholar
  215. Wenk H (2000) Die lokoregionale Lyse – heute eine Conditio sine qua non? In: Metz L, Kortmann H (Hrsg) Hersfelder Gefäßdialog 1998. Steinkopf, DarmstadtGoogle Scholar
  216. Wenk H (2001) Abdominalgefäße. In: Hartel W, Keminger K, Rehner M, Reith HB, Schreiber HW (Hrsg) Visceralchirurgie. Einhorn, Reinbek bei HamburgGoogle Scholar
  217. Wenk H, Schmid A (2008) Gefäßchirurgie. In: Henne-Bruns D, Dürig M, Kremer B (Hrsg) Chirurgie. Thieme, StuttgartGoogle Scholar
  218. Weyand CM, Wagner AD, Bjornsson J, Goronzy JJ (1996) Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 98:1642–1649PubMedPubMedCentralCrossRefGoogle Scholar
  219. Wigley FM, Wise RA, Seibold JR, McCloskey DA, Kujala G, Medsger TA Jr, Steen VD, Varga J, Jimenez S, Mayes M, Clements PJ, Weiner SR, Porter J, Ellman M, Wise C, Kaufman LD, Williams J, Dole W (1994) Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med 120(3):199–206PubMedCrossRefGoogle Scholar
  220. Wilson AM, Cooke P (2007) L-arginine supplementation in peripheral arterial disease: no benefit and possible harm. Circulation 116:188–195PubMedCrossRefGoogle Scholar
  221. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, Bolger A, Cabell CH, Takahashi M, Baltimore RS, Newburger JW, Strom BL, Tani LY, Gerber M, Bonow RO, Pallasch T, Shulman ST, Rowley AH, Burns JC, Ferrieri P, Gardner T, Goff D, Durack DT (2007) Prevention of infective endocarditis: guidelines from the American heart association: a guideline from the American heart association rheumatic fever, endocarditis, and Kawasaki disease committee, council on cardiovascular disease in the young, and the council on clinical cardiology, council on cardiovascular surgery and anesthesia, and the quality of care and outcomes research interdisciplinary working group. Circulation 116(15):1736–1754PubMedCrossRefGoogle Scholar
  222. Wilson WR, Choke EC, Dawson J, Loftus IM, Thompson MM (2008) Plasma matrix metalloproteinase levels do not predict tissue levels in abdominal aortic aneurysms suitable for elective repair. Vascular 16:248–252PubMedCrossRefGoogle Scholar
  223. Yusuf K, Murat B, Unal A, Ulku K, Taylan K, Ozerdem O, Erdal Y, Tahsin Y (2007) Inflammatory abdominal aortic aneurysm: predictors of long-term outcome in a case–control study. Surgery 142:123 (Kommentar in Surgery 143: 300)Google Scholar
  224. Zeller T, Rastan A, Schwarzwalder U et al (2004) Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: six-month results from a single-center experience. J Endovasc Ther 11:676–685PubMedCrossRefGoogle Scholar
  225. Zucker S, Jian C (2010) Matrix metalloproteinases and cancer cell invasion/metastasis. In: Bagley RG (Hrsg) The tumor microenvironment (cancer drug discovery and development). Springer, Berlin/Heidelberg/New York, S 531–554Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  1. 1.Klinik und Poliklinik für GefäßmedizinUniversitätsklinikum Hamburg-EppendorfHamburgDeutschland
  2. 2.Klinik und Poliklinik für GefäßmedizinUniversitätsklinikum Hamburg-Eppendorf (UKE)HamburgDeutschland

Personalised recommendations